Pacific Biosciences Of California Basic EPS 2010-2025 | PACB
Pacific Biosciences Of California basic eps from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Pacific Biosciences Of California Annual Basic EPS | |
|---|---|
| 2024 | $-1.13 |
| 2023 | $-1.21 |
| 2022 | $-1.40 |
| 2021 | $-0.89 |
| 2020 | $0.18 |
| 2019 | $-0.55 |
| 2018 | $-0.76 |
| 2017 | $-0.87 |
| 2016 | $-0.83 |
| 2015 | $-0.42 |
| 2014 | $-0.94 |
| 2013 | $-1.26 |
| 2012 | $-1.69 |
| 2011 | $-2.03 |
| 2010 | $-14.10 |
| 2009 | $-173.03 |
| Pacific Biosciences Of California Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $-1.44 |
| 2024-12-31 | $0.02 |
| 2024-09-30 | $-0.22 |
| 2024-06-30 | $-0.64 |
| 2024-03-31 | $-0.29 |
| 2023-12-31 | $-0.31 |
| 2023-09-30 | $-0.26 |
| 2023-06-30 | $-0.28 |
| 2023-03-31 | $-0.36 |
| 2022-12-31 | $-0.37 |
| 2022-09-30 | $-0.34 |
| 2022-06-30 | $-0.32 |
| 2022-03-31 | $-0.37 |
| 2021-12-31 | $-0.31 |
| 2021-09-30 | $0.08 |
| 2021-06-30 | $-0.21 |
| 2021-03-31 | $-0.45 |
| 2020-12-31 | $0.46 |
| 2020-09-30 | $-0.14 |
| 2020-06-30 | $-0.15 |
| 2020-03-31 | $0.01 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-0.19 |
| 2019-06-30 | $-0.16 |
| 2019-03-31 | $-0.20 |
| 2018-12-31 | $-0.20 |
| 2018-09-30 | $-0.19 |
| 2018-06-30 | $-0.17 |
| 2018-03-31 | $-0.20 |
| 2017-12-31 | $-0.16 |
| 2017-09-30 | $-0.19 |
| 2017-06-30 | $-0.26 |
| 2017-03-31 | $-0.26 |
| 2016-12-31 | $-0.20 |
| 2016-09-30 | $-0.19 |
| 2016-06-30 | $-0.21 |
| 2016-03-31 | $-0.23 |
| 2015-12-31 | $-0.01 |
| 2015-09-30 | $0.02 |
| 2015-06-30 | $-0.16 |
| 2015-03-31 | $-0.27 |
| 2014-12-31 | $-0.26 |
| 2014-09-30 | $-0.13 |
| 2014-06-30 | $-0.27 |
| 2014-03-31 | $-0.28 |
| 2013-12-31 | $-0.25 |
| 2013-09-30 | $-0.31 |
| 2013-06-30 | $-0.33 |
| 2013-03-31 | $-0.37 |
| 2012-12-31 | $-0.38 |
| 2012-09-30 | $-0.41 |
| 2012-06-30 | $-0.40 |
| 2012-03-31 | $-0.50 |
| 2011-12-31 | $-0.41 |
| 2011-09-30 | $-0.54 |
| 2011-06-30 | $-0.42 |
| 2011-03-31 | $-0.66 |
| 2010-12-31 | $125.77 |
| 2010-09-30 | $-39.70 |
| 2010-06-30 | $-51.20 |
| 2010-03-31 | $-48.97 |
| 2009-12-31 | |
| 2009-09-30 | $-46.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.450B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.994B | 82.78 |
| Thermo Fisher Scientific (TMO) | United States | $160.877B | 19.46 |
| Edwards Lifesciences (EW) | United States | $44.810B | 29.38 |
| IDEXX Laboratories (IDXX) | United States | $43.334B | 49.80 |
| Alcon (ALC) | Switzerland | $42.937B | 29.02 |
| DexCom (DXCM) | United States | $32.843B | 50.76 |
| IQVIA Holdings (IQV) | United States | $28.453B | 15.94 |
| Mettler-Toledo (MTD) | United States | $25.075B | 29.82 |
| STERIS (STE) | Ireland | $22.878B | 25.20 |
| Waters (WAT) | United States | $20.696B | 29.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.375B | 0.00 |
| Hologic (HOLX) | United States | $14.463B | 15.71 |
| Sysmex ADR (SSMXY) | Japan | $10.481B | 29.73 |
| Penumbra (PEN) | United States | $9.596B | 75.32 |
| Masimo (MASI) | United States | $8.802B | 32.47 |
| Globus Medical (GMED) | United States | $7.662B | 18.26 |
| Glaukos (GKOS) | United States | $5.853B | 0.00 |
| Teleflex (TFX) | United States | $5.289B | 8.73 |
| TransMedics (TMDX) | United States | $4.219B | 91.71 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.204B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.544B | 15.15 |
| Veracyte (VCYT) | United States | $2.082B | 29.21 |
| Nihon Kohden (NHNKY) | Japan | $1.949B | 22.35 |
| Elekta AB (EKTAY) | Sweden | $1.931B | 17.36 |
| Alphatec Holdings (ATEC) | United States | $1.696B | 0.00 |
| Artivion (AORT) | United States | $1.306B | 122.32 |
| Tandem Diabetes Care (TNDM) | United States | $1.107B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.045B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.010B | 5.37 |
| SiBone (SIBN) | United States | $0.774B | 0.00 |
| IRadimed (IRMD) | United States | $0.754B | 38.27 |
| Beta Bionics (BBNX) | United States | $0.579B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.571B | 12.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.87 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| AxoGen (AXGN) | United States | $0.523B | 0.00 |
| RxSight (RXST) | United States | $0.520B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.502B | 11.77 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.430B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.06 |
| Biosig Technologies (BSGM) | United States | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.226B | 0.00 |
| Inogen (INGN) | United States | $0.195B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| Accuray (ARAY) | United States | $0.142B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.10 |
| Spectral AI (MDAI) | United States | $0.072B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.72 |